Literature DB >> 6777388

Chemoprevention of development of colonic adenomatosis and carcinomatosis with 5-fluorouracil and ftorafur on animal model.

T Narisawa, M Sato, M Tani, T Takahashi.   

Abstract

This study deals with the treatment by chemotherapy of carcinogen-induced tumors in the colon of rats. These tumors mimic colonic adenomatosis and carcinomatosis in man. The rats were given an intrarectal (i.r.) instillation of methylnitrosourea for producing colonic tumors, and thereafter received a long-term chemotherapy which was started on nascent microscopic lesions of carcinoma. The colonic tumor incidence was significantly lower in rats treated for 10 weeks than in untreated rats. An inhibition rate of tumor development was 100% in rats with i.r. doses of 5-FU, or 57% in rats with intraperitoneal (i.p.) doses of Ftorafur. However, it was found that a few microscopic lesions of carcinoma were still present in the normal-appearing colonic mucosa, even after the completion of the effective treatment. The 10-week cessation of the treatment following the 5-week chemotherapy permitted the tumor development. The results indicate that the nascent microscopic lesions of carcinoma (premalignant lesions) in the colon can be inhibited or regulated from developing into grossly visible tumors by the effective chemotherapy, i.e., intermittent and/or long-term treatment with sensitive chemotherapeutic agents and effective way of administration.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6777388     DOI: 10.1007/bf00405773

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  22 in total

1.  SELECTIVE CYTOTOXIC EFFECT OF TOPICAL 5-FLUOROURACIL.

Authors:  C J DILLAHA; G T JANSEN; W M HONEYCUTT; A C BRADFORD
Journal:  Arch Dermatol       Date:  1963-09

2.  Studies on fluorinated pyrimidines. II. Effects on transplanted tumors.

Authors:  C HEIDELBERGER; L GRIESBACH; B J MONTAG; D MOOREN; O CRUZ; R J SCHNITZER; E GRUNBERG
Journal:  Cancer Res       Date:  1958-04       Impact factor: 12.701

3.  Phase 1 and phase 2 proliferative lesions of colonic epithelial cells in diseases leading to colonic cancer.

Authors:  M Lipkin
Journal:  Cancer       Date:  1974-09       Impact factor: 6.860

4.  Large bowel carcinogenesis in mice and rats by several intrarectal doses of methylnitrosourea and negative effect of nitrite plus methylurea.

Authors:  T Narisawa; C Q Wong; R R Maronpot; J H Weisburger
Journal:  Cancer Res       Date:  1976-02       Impact factor: 12.701

5.  Mitomycin C bladder instillation therapy for bladder tumors.

Authors:  T Mishina; K Oda; S Murata; H Ooe; Y Mori
Journal:  J Urol       Date:  1975-08       Impact factor: 7.450

Review 6.  Multimodal immunotherapy of primary gastrointestinal tumors in rats. 1. Histologic correlation.

Authors:  B R Bansal; J Mobini; S C Bansal
Journal:  Cancer       Date:  1978-11       Impact factor: 6.860

7.  Cancer chemotherapy model using autochthonous large bowel cancer in rats.

Authors:  T Narisawa; K Kono; T Yamaguchi; T Takahashi
Journal:  Gan       Date:  1978-06

8.  Chemoprevention of development of colonic adenomatosis and carcinomatosis with intrarectal dose of 5-FU on animal model.

Authors:  T Narisawa; K I Kohno; T Yamaguchi; T Takahashi
Journal:  Cancer       Date:  1980-02       Impact factor: 6.860

9.  Corynebacterium parvum enhances colonic cancer in dimethylhydrazine-treated rats.

Authors:  J P Cruse; M R Lewin; C G Clark
Journal:  Br J Cancer       Date:  1978-04       Impact factor: 7.640

10.  Mucous secretion in rat colonic mucosa during carcinogenesis induced by dimethylhydrazine. A morphological and histochemical study.

Authors:  M I Filipe
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

View more
  1 in total

1.  Chemotherapy of chemically-induced colorectal tumours.

Authors:  J M Gilbert; E M Thompson; G Slavin; A E Kark
Journal:  J R Soc Med       Date:  1983-06       Impact factor: 5.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.